Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopain (MTX-071 / resiniferatoxin) in chronic osteoarthritic knee pain
2017-004049-26Phase 2Completed
- Sponsor
- Mestex
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Lopain in knee osteoarthritis (OA) and osteoarthritis (OA), sponsored by Mestex. Primary endpoint: Occurrence of adverse events. Started Oct 2017; status: completed.
02
Drugs
Lopain
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-004049-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004049-26.